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Background: Treatment of recurrent depressive disorders is currently only moderately
successful. Increasing evidence suggests a significant relationship between adverse
childhood experiences and recurrent depressive disorders, suggesting that trauma-
based interventions could be useful for these patients.
Objectives: To investigate the efficacy of Eye Movement Desensitization and
Reprocessing therapy (EMDR) in addition to antidepressant medication (ADM) in treating
recurrent depression.
Design: A non-inferiority, single-blind, randomized clinical controlled trial comparing
EMDR or CBT as adjunctive treatments to ADM. Randomization was carried out by
a central computer system. Allocation was carried out by a study coordinator in each
center.
Setting: Two psychiatric services, one in Italy and one in Spain.
Participants: Eighty-two patients were randomized with a 1:1 ratio to the EMDR
group (n = 40) or CBT group (n = 42). Sixty-six patients, 31 in the EMDR
group and 35 in the CBT group, were included in the completers analysis.
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Intervention: 15 ± 3 individual sessions of EMDR or CBT, both in addition to ADM.
Participants were followed up at 6-months.
Main outcome measure: Rate of depressive symptoms remission in both groups, as
measured by a BDI-II score <13.
Results: Sixty-six patients were analyzed as completers (31 EMDR vs. 35 CBT). No
significant difference between the two groups was found either at the end of the
interventions (71% EMDR vs. 48.7% CBT) or at the 6-month follow-up (54.8% EMDR
vs. 42.9% CBT). A RM-ANOVA on BDI-II scores showed similar reductions over time in
both groups [F (6,59) = 22.501, p < 0.001] and a significant interaction effect between
time and group [F (6,59) = 3.357, p = 0.006], with lower BDI-II scores in the EMDR
group at T1 [mean difference = –7.309 (95% CI [–12.811, –1.806]), p = 0.010]. The
RM-ANOVA on secondary outcome measures showed similar improvement over time
in both groups [F (14,51) = 8.202, p < 0.001], with no significant differences between
groups [F (614,51) = 0.642, p = 0.817].
Conclusion: Although these results can be considered preliminary only, this study
suggests that EMDR could be a viable and effective treatment for reducing depressive
symptoms and improving the quality of life of patients with recurrent depression. Trial
registration: ISRCTN09958202.
Keywords: EMDR, CBT, depression, traumatic stress, anxiety, quality of life, antidepressants, randomized
controlled trial
INTRODUCTION
Depression is one of the most common mental disorders,
affecting more than 300 million people (WHO, 2017). The
consequences of this disorder in terms of health loss are huge.
WHO has ranked depression as “the single largest contributor
to global disability, accounting for 7.5% of all years lived with
disability in 2015” (WHO, 2017).
Although over the last 20 years the options for depression
therapy have increased significantly, the optimism that initially
accompanied the use of new antidepressant medications (ADMs),
such as selective reuptake inhibitors of serotonin (SSRIs),
disappeared rapidly (Pampallona et al., 2002). In fact, several
meta-analyses have concluded that ADMs have only a modest
advantage over placebos (Kirsch et al., 2008; Khan and Brown,
2015), though with greater benefits in the case of severe
depression (Fournier et al., 2010).
Depression treatment also involves the use of
psychotherapeutic interventions, which have proved effective not
only in mild and moderate depression but also in severe chronic
depression (Nemeroff et al., 2003).
Guidelines indicate that for people with moderate or severe
depression the most effective treatment is a combination of
ADMs and a high-intensity psychological intervention (National
Collaborating Centre for Mental Health [UK], 2010). Cognitive
Behavioral Therapy (CBT) is one of the best known, empirically
supported treatments for depression (National Collaborating
Centre for Mental Health [UK], 2010). CBT is based on the
premise that maladaptive cognitions contribute to the onset and
maintenance of depression. According to Beck’s model, a change
in these maladaptive cognitions can lead to changes in emotional
regulation and dysfunctional behaviors (Beck, 1979).
In recent years, much evidence has accumulated highlighting
the role of stress and its neurobiological correlates in both the
occurrence and development of major psychiatric disorders,
including depression (Nemeroff, 2016). The exposure to
adverse childhood experiences (ACEs), which includes
physical and sexual abuse as well as emotional neglect
(Felitti et al., 1998; Norman et al., 2012; Infurna et al.,
2016), is associated with a marked increase in the risk of
developing depression in adulthood (Kendler et al., 1995;
Anda et al., 2006; American Psychiatric Association, 2013;
Lindert et al., 2014; Khan et al., 2015; Infurna et al., 2016;
Kendler and Gardner, 2016; Nemeroff, 2016; Hughes et al.,
2017).
Compared with individuals who have not experienced adverse
events in childhood, those with a history of such experiences are
at greater risk of having a depressive episode in their lifetime
(Kessler, 1997). A graded relationship between the number of
ACEs and the probability of lifetime and recent depressive
disorders has also been highlighted (Chapman et al., 2004; Anda
et al., 2006).
Moreover, several studies have shown that ACEs are associated
with a poorer clinical course of depression, including earlier age
of onset, greater severity of symptoms, co-morbidity, and episode
persistence and recurrence (Heim and Nemeroff, 2001; Wiersma
et al., 2009; Scott et al., 2012; Tunnard et al., 2014; Paterniti et al.,
2017).
Several studies have investigated the effect of ACEs on
the course of major depressive disorder (MDD), pointing out
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a strong association between a history of adverse events in
childhood and the course of depression in adulthood (Widom
et al., 2007; Infurna et al., 2016; Li et al., 2016). Also, a
recent meta-analysis (Nanni et al., 2012) has suggested that
childhood maltreatment is associated with an elevated risk
of the recurrence and persistence of depressive symptoms. In
addition, Chen J. et al. (2014) recently showed a significant
association between childhood sexual abuse and recurrent major
depression, with earlier age of onset and longer depressive
episodes for depressed women who experienced sexual abuse in
their childhood.
The clear recognition that patients with major depression
who have experienced ACEs exhibit an unfavorable course of
depression and a poor response to standard treatments, thereby
incurring a greater risk of recurrent and persistent depressive
episodes, suggests that it is essential to develop novel therapeutic
approaches specifically tailored to treating traumatic experiences
(Nanni et al., 2012; van Nierop et al., 2015; Nemeroff, 2016;
Williams et al., 2016).
Eye Movement Desensitization and Reprocessing (EMDR)
therapy was originally developed by Francine Shapiro in the late
1980s to treat traumatic memories (Shapiro, 1989). It is now
widely recognized as an empirically supported treatment for post-
traumatic stress disorder (PTSD) (National Collaborating Centre
for Mental Health [UK], 2005; Bisson and Andrew, 2007; Chen
Y.-R. et al., 2014).
EMDR therapy is guided by the Adaptive Information
Processing (AIP) model (Shapiro, 2001). One of the key aspects
of the AIP model is that stressful events that have not been fully
processed and integrated into already existing memory networks
are stored in a dysfunctional way. These stressful events do not
necessarily fulfill Criterion A for PTSD and are the basis of several
mental disorders, including PTSD, affective disorders, chronic
pain, and addiction (Shapiro, 2014; Hase et al., 2017). A recent
study (Hase et al., 2017) proposed a link between dysfunctionally
stored memory and the theory of pathogenic memory, previously
described by Centonze et al. (2005).
The reactivation of a pathogenic memory induced by various
internal and external stimuli, also exerting vegetative arousal,
could lead to subsequent maladaptive responses, which in the
long-term could contribute to the onset of various psychiatric
disorders (Hase et al., 2017). From this perspective, it could be
hypothesized that pathogenic memories contribute to the onset
and maintenance of recurrent depression episodes. By promoting
the reprocessing of pathogenic memories, EMDR may represent a
promising approach and thus could broaden the range of effective
interventions for this disorder.
In recent years, the application of EMDR beyond PTSD has
expanded rapidly. It is currently being used as a treatment for
a wide range of disorders that follow distressing life experiences
(Shapiro and Maxfield, 2002). Several books, conference
presentations, and case reports suggest its applicability in
treating depression too (Wood and Ricketts, 2013; Luber,
2016).
Two studies reviewing the literature on the application of
EMDR to depression as primary diagnosis concluded that EMDR
showed preliminary promise as a therapy for treating this
disorder, although further research was required (Wood and
Ricketts, 2013; Valiente-Gómez et al., 2017).
More recently, other studies have reported evidence of EMDR
efficacy in patients with depression (Hofmann et al., 2014;
Behnammoghadam et al., 2015; Hase et al., 2015; Mauna Gauhar,
2016), while a specific EMDR therapy protocol for the treatment
of depressive disorders has been published (Hofmann et al.,
2016). Moreover, a recently published study has shown the
feasibility of using EMDR treatment in patients with recurrent
and/or long-term depression (Wood et al., 2017).
In 2010, a group of European researchers founded the
European Depression EMDR Network (EDEN) with the
purpose of evaluating the efficacy of EMDR in this disorder
in different contexts and with different methodologies. The
underlying hypothesis is that EMDR therapy could directly
address memories of adverse and traumatic experiences that
are significant contributors to the onset and maintenance of
depressive episodes.
The present study represents one of the Network’s research
projects, its aim being to assess whether patients with
recurrent depressive disorders benefit from a trauma-adapted
psychotherapeutic intervention (EMDR) compared with a more
classical intervention (CBT), in addition to standard clinical
management and medication.
The primary aim of the study was to evaluate the efficacy
of EMDR compared with CBT in terms of response rates and
time frame of depressive symptoms remissions. A secondary aim
was to compare the efficacy of both treatments on associated
symptoms and quality of life.
MATERIALS AND METHODS
Design
This study was a non-inferiority, randomized controlled clinical
trial investigating the efficacy of EMDR treatment compared with
CBT intervention in patients with recurrent depressive disorder
already undergoing “treatment as usual” (TAU).
The study is registered in the ISRNCTN registry as
ISRCTN09958202.
Setting
The study was a multicenter trial, and therefore patients were
consecutively recruited between 2014 and 2016 from two settings:
in Italy, participants were recruited from the psychiatric services
affiliated with the University Hospital San Luigi Gonzaga of
Orbassano, Turin; in Spain, patients were enrolled at the
Assistens Clinic, A Coruña.
This study was approved by the Research Ethics Committee
of the University Hospital San Luigi Gonzaga and by the Ethical
Committee of Clinical Research of Galicia. Informed written
consent was obtained from all participants.
Participants
The participants in the study consisted of 82 patients with
recurrent depressive episodes, who had been referred to one
of the two above-mentioned specialized clinical services and
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were already receiving TAU (ADMs and psychiatric visits, with
stabilized ADMs for at least four weeks).
Participants were pre-screened using the Beck Depression
Inventory-II (BDI-II; Beck and Steer, 1993) during a routine
clinical visit. Those with a score on BDI-II greater than 13
(considered the clinical cut-off for screening of depression
symptoms) were assessed using the Mini-International
Neuropsychiatric Interview-Plus (MINI-Plus; Sheehan et al.,
1998) clinical interview, in order to confirm the diagnosis.
Inclusion criteria were as follows: (1) a diagnosis of
recurrent depressive disorder (F33.x or F33.x + F34.1 “double
depression”)— this could be chronic depression (of at least two
years’ duration); (2) aged between 18 and 65 years; (3) a score of
at least 13 on Beck’s Depression Inventory-II (BDI-II); (4) having
received ADM treatment for at least four weeks; (5) legal capacity
to consent to the treatment.
Exclusion criteria were as follows: (1) a history of psychotic
symptoms or schizophrenia; (2) bipolar disorder or dementia;
(3) cluster A and B severe personality disorders; (4) dissociative
disorders (DES score >25%); (5) any substance-related abuse
or dependence disorder (except those involving nicotine) in the
6 months prior to the study; (6) a serious, unstable medical
condition; (7) being pregnant; (8) undergoing parallel legal
processes or applications for pension or social security.
Recruitment and Measures
The recruitment of participants was carried out by psychiatrists,
who proposed their participation in the research protocol to
patients during a routine clinical visit.
The research protocol and aims of the study were explained to
patients who met the inclusion/exclusion criteria. They were also
told that if they took part in the study they would be randomly
assigned to one of two treatment conditions, both employing
the same timing and assessment tools, for the period of the
study. If they agreed they signed the informed consent, were
randomized, and then asked to proceed with the psychological
assessment.
The following psychological self-report questionnaires were
administered:
Beck Depression Inventory-II (BDI) (Beck and Steer,
1993)
This is a 21-item self-report instrument that assesses the presence
and severity of depressive symptoms, based on DSM-IV criteria.
The total score ranges from 0 to 63, with higher scores indicating
higher levels of depression. A score greater than 13 is considered
the cut-off for the presence of depressive symptoms (14−19:
mild depression; 20−28: moderate depression; ≥29: severe
depression).
Beck Anxiety Inventory (BAI) (Beck and Steer, 2013)
This is a 21-item self-report measure that assesses cognitive,
somatic, and affective anxiety symptom severity. The total score
ranges from 0 to 63, with higher scores indicating higher levels
of anxiety. A score above 9 suggests the presence of clinical
anxiety (10−16: mild anxiety; 17−29: moderate anxiety; ≥30:
severe anxiety).
Impact of Event Scale-Revised (IES-R) (Weiss and
Marmar, 1997)
The IES-R is a 22-item self-report questionnaire consisting of
three subscales (eight items relate to intrusions, eight items
evaluate avoidance, and six items assess hyperarousal). The
overall scale assesses subjective distress caused by traumatic
events.
WHO-Quality of Life Bref (WHOQOL-Bref) (Murphy
et al., 2000)
The WHOQOL-Bref consists of 26 items that measure the
following broad domains: physical health (WHO-Phys);
psychological health (WHO-Psychol); social relationships
(WHO-Social); and environment (WHO-Env).
Global Assessment of Functioning Scale (GAF)
(American Psychiatric Association, 2000)
This scale is included in the V Axis of DSM-IV and is used by
mental health providers to rate patients’ social, occupational, and
psychological functioning. Scores range from 100 (extremely high
functioning) to 1 (severely impaired).
The following tools were administered at the beginning of the
study only:
The Dissociative Experiences Scale (DES) (Bernstein
and Putnam, 1986; Frischholz et al., 1990)
It is a brief, 28-item self-report inventory of the frequency
of dissociative experiences. It is a reliable and valid measure
for determining the contribution of dissociation to various
psychiatric disorders and a screening instrument for dissociative
disorders. In this study, a score above 25 was considered an
exclusion criterion.
The Trauma Antecedent Questionnaire (TAQ)
(Luxenberg et al., 2001)
It is a self-administered instrument that gathers information
about ACEs and other life experiences, assessed at four different
age periods: early childhood (birth to 6 years), latency (7 to
12 years), adolescence (13 to 18 years), and adulthood. For each
item of the TAQ, respondents are asked to rate the extent to which
they have had a particular experience during each developmental
period on a scale from 0 to 3. Presence of ACE is calculated when
at least one adverse experience of an intensity of at least 2 is
reported.
Randomization and Assessment Points
Patients were randomly allocated to one of the two conditions:
TAU+EMDR or TAU+CBT. Patients were randomized at a 1:1
ratio, using a block-wise randomization sequence (block size of
four). The sequence was determined by an independent statistical
consultant, blind to the initial assessments in order to ensure that
allocation remained unknown, using a centralized randomization
algorithm.
In each center, treatment allocation was communicated to
the patients by the study coordinator to ensure that evaluators
remained blind to their allocation.
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The psychological assessment was performed by psychologists
independent of the research protocol, using the same tools and
at the same time periods for both groups: at baseline (T0), at
the end of the treatment (T1), and 6 months after the end of the
treatment (T2).
In order to assess the trend of depressive symptoms, four
clinical management visits were also scheduled for each patient
during the treatment phase. The first assessment (Assess-1)
was scheduled after the first two treatment sessions, and
each successive assessment (Assess-2, Assess-3, and Assess-4)
was conducted every four treatment sessions. During these
intra-treatment assessments, psychiatrists independent of the
research protocol administered the Beck Depression Inventory-II
only.
Interventions
The clinical psychologists conducting the clinical assessments
were both independent and blind to the interventions.
All patients in the study continued to receive Treatment as
Usual, which comprised ADMs and the clinical management
provided by each center.
The number of adjunctive EMDR or CBT individual sessions
was allowed to vary between 12 and 18 (15 ± 3). This
relatively flexible range of sessions was chosen with a twofold
aim: (1) to avoid any large disparity in treatment between
patients and centers, as no therapist would be allowed to
schedule a number of sessions <12, or >18; (2) to allow
therapists to schedule the appropriate number of sessions for each
patient, albeit within the defined range, according to patients’
needs.
The sessions were scheduled on a weekly basis where
possible. The duration of the intervention depended mainly
on the number of sessions completed by each patient. Overall,
it varied from between three and 6 months (e.g., when a
period of vacation interrupted the treatment phase or logistical
difficulties made it difficult for a patient to maintain a weekly
schedule).
Eye Movement Desensitization and Reprocessing
The EMDR treatment followed the DeprEnd protocol;
that is, the manual for EMDR in the treatment of
depressive patients (see Hofmann et al., 2016 for a detailed
explanation).
Eye Movement Desensitization and Reprocessing therapy
intervention started with a stabilization phase consisting of
two stages: in the first two sessions, the Safe Place procedure
(Shapiro, 2001) and the Absorption technique (Hofmann, 2009)
were used. The second phase, lasting for the following three
sessions, was based on Self-care procedures (Gonzalez-Vázquez
and Mosquera-Barral, 2012).
The remaining sessions focused on trauma reprocessing.
EMDR targets were selected taking into account four factors
that play a major role in the emergence, maintenance, and
recurrence of depressive episodes. Depending on the individual
life history of the patient, one or all of the following forms
of pathogenic memory networks became a focus of EMDR
treatment:
(1) Episode triggers of the current depressive episode (and
earlier episodes): when depressive episodes appear to be
triggered for the most part by either traumatic (PTSD
Criterion A) or non-traumatic (not fulfilling Criterion A)
events;
(2) Belief systems: when a patient undergoes a series of
repeated experiences (mostly non-Criterion A events, like
humiliation) that become crystallized in the form of belief
systems, increasing vulnerability and the maintenance of
depressive episodes;
(3) Depressive states: when patients experience earlier, longer,
more intense, or repeated depressive episodes that can be
remembered in a state-specific way;
(4) Depressive and suicidal states: when the memory of
depression and/or suicidality itself (or suicide attempts)
has created a memory structure of its own.
The EMDR targets were prioritized according to the clinical
state of the patient.
In each center, EMDR was provided by three psychotherapists
specializing in Level II EMDR and with a minimum of three
years of experience in treating patients with depression. They
received extensive training and supervision in the manualized
protocol established for the study, from a certified senior EMDR
instructor.
Cognitive Behavioral Treatment
The CBT treatment followed the manual of cognitive
therapy for depression (Beck, 1979). The therapy works
systematically with dysfunctional beliefs and teaches self-
monitoring of negative emotions and their influence on
behaviors. In addition, it includes decision-making training
and targeted work on how to increase the frequency and
quality of pleasant experiences. Homework assignments
help patients to improve social skills in their everyday
life.
In each center, CBT treatment was performed by three
psychotherapists with certified training in CBT techniques and
a minimum of three years’ experience in treating patients
with depression. They received regular CBT supervision
to ensure that the quality of their CBT treatment was
maintained.
Sample Size
Given the trial’s non-inferiority design [Null hypothesis H0:
pi2−pi1 ≤–0,2 (non-inferiority)], sample size estimation was
based on the formula of Farrington and Manning, the maximum
likelihood method (Farrington and Manning, 1990), and
implemented by ADDPLAN 4.0.3 software [Adaptive Design and
Analyses, ADDPLAN 4.0.3. ADDPLAN GmbH, 2002 Cologne].
In the analysis, a single stage (fixed sample size) design and an
allocation ratio (n2/n1) = 1 were considered.
For specified α = 0.05, rates pi1 = 0.3, and pi2 = 0.4 (odds ratio
of 1.556), 62 patients (31 per group) were needed to reach a power
(1–β) equal to 80.0%. In order to take 25% of dropouts and loss
to follow up into account, we planned to include a total number
of 82 patients.
Frontiers in Psychology | www.frontiersin.org 5 February 2018 | Volume 9 | Article 74
fpsyg-09-00074 February 12, 2018 Time: 17:4 # 6
Ostacoli et al. EMDR vs. CBT for Depression
Statistical Analyses
Data were processed and analyzed using the Statistical
Package for Social Sciences (SPSS version 22.0; Chicago, IL,
United States).
Both parametric and non-parametric tests were used, in
accordance with Shapiro–Wilk, as a test for normality. Baseline
group differences were assessed using Student’s t-test or Mann–
Whitney U test to compare the two groups on continuous
measures, and Fisher’s Exact Test for categorical measures.
The primary outcome of the study was the rate of depressive
symptoms remission in both groups, as measured by a BDI-II
score <13. Based on the BDI-II score, patients were classified
as either asymptomatic or symptomatic (BDI-II score <13/≥13,
respectively) and with or without symptoms remission (BDI-
II score <9/≥9, respectively), while the difference between the
EMDR and CBT groups at T1 and T2 was analyzed using Fisher’s
Exact Test.
Another primary aim was to compare the time frame of
depressive symptoms reduction in the two groups. A GLM
repeated measures ANOVA (RM-ANOVA) was used to analyze
the effects of time and the interaction between time and groups
(EMDR vs. CBT) for BDI-II levels across the multiple assessment
points.
A secondary outcome of the study was to compare the
efficacy of both treatments on associated symptoms and quality
of life. A GLM repeated measures multivariate ANOVA (RM-
MANOVA) was used to analyze the main pre- and post-
intervention effects and interactions both between and within
EMDR and CBT groups for the other clinical variables (BAI,
IES-Total, WHO, GAF).
The results are shown as F (V1, V2), with V1 and V2 as
numerator and denominator degrees of freedom, respectively.
Pairwise comparison between both groups and times was
achieved by simple contrast and reported as means difference
with Sidak correction 95% Confidence Interval (95%CI) for
multiple comparisons.
Finally, an exploratory intention-to-treat analysis (ITT) was
performed on the primary outcome only (i.e., BDI-II scores), with
missing data accounted for using Multiple Imputation models
(Howell, 2008).
A p < 0.05 was considered statistically significant for all the
analyses.
RESULTS
Figure 1 shows a flow diagram with the number of participants
at each assessment stage. A total of 159 patients were screened
using the BDI-II; 56 patients were excluded on the basis of the
inclusion/exclusion criteria (35.2%); and 21 refused to participate
(refusal rate: 20.4%); reasons given for refusal were mainly the
distance of patients’ place of residence from the place of treatment
and the inability to attend the psychiatric and psychotherapeutic
sessions). Eighty-two patients were randomized: 40 were assigned
to the EMDR intervention and 42 to the CBT intervention. Four
patients did not begin the treatment (three in the EMDR group
and one in the CBT group), and five patients (three in the EMDR
group and two in the CBT group) attended fewer than half of
the treatment sessions. These patients refused to continue with
the assessment at post-treatment and follow-up assessments and
therefore it was not possible to include them in the statistical
analysis. Moreover, seven patients were lost to the follow-up
evaluation.
Therefore, a total of 66 patients (31 in the EMDR group and
35 in the CBT group) were included in the per-protocol statistical
analysis.
Table 1 presents the socio-demographic and clinical
characteristics of these patients at baseline. There were no
significant differences in demographics or clinical characteristics
between the two groups at baseline (T0). In particular, both
groups reported a high proportion of ACEs in the 0−18 years
age period (96.7% in the EMDR group and 94.3% in the CBT
group; p = 1.000). At the same time, no patient reported any
co-morbidity with PTSD, as assessed by the MINI-Plus clinical
interview at baseline.
The number of individual treatment sessions was similar for
both groups (EMDR: M = 15.1, SD = 1.11; CBT: M = 14.6,
SD = 1.77; p = 0.209).
First, for our primary outcome measure we examined the
proportion of patients who no longer had a BDI-II score above
the cut-off (i.e., BDI-II score > 13) at the end of the treatment
(T1) and at follow-up assessment (T2). At T1 we found that 22
out of 31 patients (71.0%) in the EMDR group and 17 out of 35
patients (48.7%) in the CBT group did not have a score above the
clinical cut-off for depression. At T2 we found that 17 out of 31
(54.8%) in the EMDR group and 15 out of 35 patients (42.9%) in
the CBT group did not have a BDI-II score above the clinical cut-
off. No significant difference between the two groups was found
at either T1 or T2.
We also examined the proportion of patients who recorded a
BDI-II score below 9, which is considered the clinical threshold
for complete symptoms remission. At T1, 18 out of 31 patients
(58.1%) in the EMDR group and 11 out of 35 patients (31.4%)
in the CBT group had a BDI-II score <9, with a statistically
significant difference in favor of the EMDR group (χ2 = 4.735,
p = 0.046). At T2 we found that 13 out of 31 patients (41.9%) in
the EMDR group and 13 out of 35 patients (37.1%) in the CBT
group had a BDI-II score below 9, with no significant difference
between the two groups.
We then investigated whether the different psychotherapy
treatments (EMDR or CBT) had a different impact on BDI-II
trend over time. A repeated-measures ANOVA was performed
comparing group and time effects as well as interactions between
group and time for BDI-II scores across the seven assessment
points (i.e., baseline, four assessments during treatments, post-
treatment, and 6-month follow-up). Descriptive scores are shown
in Figure 2. The RM-ANOVA yielded a significant time main
effect [F(6,59) = 22.501, p< 0.001], showing significantly reduced
BDI-II scores over time for both groups. The RM-ANOVA also
revealed a significant interaction effect between time and group
[F(6,59) = 3.357, p = 0.006]. Planned post hoc analyses of simple
effects with Sidak correction showed a significant difference
between the two groups at post-treatment (T1), with lower BDI-
II scores in the EMDR group (M = 10.55, SE = 2.006) compared
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FIGURE 1 | Participants flow diagram.
with those in the CBT group (M = 17.86, SE = 1.888), with
mean difference = –7.309 (95% CI [–12.811, –1.806]), p = 0.010
(Figure 2). Post hoc analysis of simple effects also showed a
similar trend of reduction in both groups until Assessement-
2, with both showing a significant difference between baseline
and Assessment-2 (EMDR: mean difference = 6.161 (95%CI
[1.186, 11.136]), p = 0.005; CBT: mean difference = 7.543
(95%CI [2.861, 12.225]), p < 0.001). Thereafter, the trends of
the two groups differed: the CBT group showed no statistically
significant difference between Assessment-2 and post-treatment
(T1), mean difference = 1.806 (95%CI [–4.159, 6.331]), p = 1.000,
while in the EMDR group there were a significant reduction in
BDI-II scores between Assessment-2 and post-treatment (T1),
mean difference = 11.194 (95%CI [5.620, 16.767]), p < 0.001
(Figure 2).
An ITT analysis based on Multiple Imputation models of BDI-
II trend over time was also performed on the whole randomized
sample, confirming the finding obtained in the completers
analysis of a significant difference between EMDR and CBT at
T1 (p = 0.011).
Moreover, for our secondary outcome we examined
whether the different psychotherapy treatments (EMDR
or CBT) administered to the patients had a different
impact on psychological variables relating to depression. A
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TABLE 1 | Demographic and clinical data of participants at baseline.
EMDR (N = 31)
Mean
(SD)/Median (IQR)
CBT (N = 35)
Mean
(SD)/Median (IQR)
p
Age (years) 48.23 (9.66) 47.54 (12.90) 0.810a
Education (years) 13.00 (6.3) 12.00 (7) 0.446b
Age onset depression
diagnosis
24.50 (21.3) 28.00 (24.5) 0.382b
DES 11.00 (12) 9.00 (13.5) 0.113b
n(%) n(%)
Gender 0.290c
Female 25 (80.65) 31 (88.57)
Male 6 (19.35) 4 (11.43)
Employment status 0.505c
Unemployed 5 (16.13) 4 (11.43)
Employed 22 (70.97) 24 (68.57)
Pensioned 4 (12.90) 6 (17.14)
Student 0 (0) 1 (2.86)
Marital status 0.893c
Single 9 (29.03) 8 (22.86)
Married/Cohabitee 20 (64.52) 25 (71.42)
Separated/divorced 1 (3.225) 1 (2.86)
Widowed 1 (3.225) 1 (2.86)
Depression diagnosis 0.706c
Chronic depressive
disorder
3 (9.675) 6 (17.15)
Double depression 3 (9.675) 4 (11.43)
Recurrent depressive
disorder
25 (80.65) 25 (71.42)
TAQ
0-6 21 (67.74) 25 (71.43) 0.793c
7-12 28 (90.32) 30 (85.71) 0.713c
13-18 30 (96.77) 33 (94.28) 1.000c
Adult 31 (100) 35 (100) –
EMDR, Eye Movement Desensitization and Reprocessing group; CBT, Cognitive
Behavioral Therapy group; DES, Dissociative Experience Scale; TAQ, Trauma
Antecedent Questionnaire. aPearson’s independent samples t-test. bMann-
Whitney U test. cFisher’s exact test.
repeated-measures MANOVA was performed on baseline,
post-treatment, and follow-up secondary outcome scores
(i.e., BAI, IES-R, WHO-Phys, WHO-Psychol, WHO-Social,
WHO-Env, GAF), comparing group and time effects as well
as interactions between group and time. This analysis yielded
a significant time main effect [F(14,51) = 8.202, p < 0.001],
while no significant interaction was found between time and
group [F(614,51) = 0.642, p = 0.817]. The mean participant
scores of all secondary outcome variables improved from
baseline (T0) to post-treatment (T1) and follow-up evaluation
(T2), without significant differences between the groups
(Table 2).
Planned post hoc analysis using Sidak correction showed that
in the EMDR group all the clinical scores showed improvement
both between T0 and T1 and between T0 and T2, while in the
CBT group similar improvement was observed for all variables
except WHO-Social and WHO-Env, which showed significant
improvement between T0 and T2 but not between T0 and T1
(Table 2).
DISCUSSION
Depression is the condition considered to bear the greatest
responsibility for health decrements worldwide, due to its
prevalence and its chronic and recurrent nature (WHO, 2017).
Therefore, understanding its etiology and identifying effective
and lasting treatments is a global health priority.
Antidepressant medication are the current standard of
treatment in clinical practice, but they appear to be symptom-
suppressive rather than curative (Hollon et al., 2002) and do
not appear to maintain their effectiveness in terms of reducing
future risk of depressive episodes once their course is completed
(DeRubeis et al., 2008).
Therefore, identifying additional interventions that are
effective in treating depression and reducing the risk of its
recurrence to lasting effect, is of the utmost importance.
To the best of our knowledge, this is the first randomized
controlled trial to evaluate the efficacy of EMDR in comparison
with CBT in patients affected by recurrent depression and treated
with ADM.
The most significant result highlighted by this study is that
the majority of patients were able to significantly reduce their
depression symptoms level after only 15 therapy sessions, and
to sustain this clinical benefit 6 months after the end of the
psychotherapeutic intervention.
Eye Movement Desensitization and Reprocessing therapy
treatment was shown to be as effective as CBT in reducing the
proportion of patients with a level of depressive symptoms above
the clinical threshold, both at the end of the treatment and
6 months later, with response rates similar to those reported in
previous studies (DeRubeis et al., 2005; Hollon et al., 2005).
At the same time, EMDR exceeded CBT in terms of the
proportion of patients who could be considered to be in remission
after the end of the interventions. In addition, the results
for depressive symptoms trend showed that both interventions
were effective in reducing clinical levels of depression, with a
significant difference in favor of EMDR treatment at the end of
the intervention phase. This difference was no longer present at
the 6-month follow-up, although in the EMDR group there was
a tendency to remain below the clinical threshold that was not
apparent in the CBT group.
Interestingly, EMDR and CBT showed a similar trend of
clinical improvement in depressive symptoms in the initial phase
of the intervention (i.e., until Assessment-2), but then exhibited
different trajectories between Assessment-2 and post-treatment
(T1). In this second phase, EMDR continued to significantly
reduce depression levels until the end of the intervention, while
CBT only maintained the gains made in the first phase. It
is possible to interpret this result by looking in-depth at the
contents of the treatment sessions. In the first four to five sessions,
EMDR treatment focused on assessment and stabilization, thus
exerting a similar effect to that of CBT. After EMDR’s specific
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FIGURE 2 | Trend of BDI-II scores for the two groups [Eye Movement Desensitization and Reprocessing group (EMDR) and Cognitive Behavioral Therapy group
(CBT)].
TABLE 2 | Comparison of clinical variables between T0, T1, and T2 for the two groups (EMDR and CBT).
Pre-treatment (T0) Post-treatment (T1) 6 month follow-up (T2) Time effect∗
EMDR
(N = 31)
CBT
(N = 35)
EMDR
(N = 31)
CBT
(N = 35)
EMDR
(N = 31)
CBT
(N = 35)
BAI 23.23 (10.77) 27.94 (13.69) 13.55 (10.47) 19.03 (12.80) 12.61 (9.82) 17.80 (13.55) F (2,128) = 33.549, p < 0.001; η2p = 0.344
IES-R 39.29 (20.74) 37.49 (23.39) 23.00 (21.81) 26.97 (22.77) 20.23 (17.92) 24.49 (21.88) F (2,128) = 27.421, p < 0.001; η2p = 0.300
WHO-Phys 11.34 (2.31) 11.92 (2.32) 13.05 (2.28) 13.08 (2.53) 13.27 (2.10) 13.31 (2.79) F (2,128) = 13.457, p < 0.001; η2p = 0.174
WHO-Psychol 9.53 (1.83) 9.24 (1.46) 12.02 (2.25) 10.69 (2.54) 11.99 (2.47) 11.05 (2.50) F (2,128) = 28.945, p < 0.001; η2p = 0.311
WHO-Social 10.92 (2.52) 11.16 (2.46) 12.60 (2.38) 11.70 (2.19) 12.73 (2.62) 12.53 (3.09) F (2,128) = 9.395, p < 0.001; η2p = 0.128
WHO-Env 12.37 (2.11) 12.26 (2.20) 13.42 (1.74) 12.74 (2.12) 13.29 (1.77) 13.09 (2.29) F (2,128) = 8.405, p < 0.001; η2p = 0.116
GAF 68.10 (11.90) 63.66 (16.93) 77.90 (10.97) 74.60 (17.84) 77.87 (13.09) 74.94 (10.72) F (2,128) = 23.557, p < 0.001; η2p = 0.269
Data are mean (SD). EMDR, Eye Movement Desensitization and Reprocessing group; CBT, Cognitive Behavioral Therapy group; BAI, Beck Anxiety Inventory; IES-R, Impact
of Event Scale-Revised; WHO-Phys, WHO-Quality of Life Bref-Physical health; WHO-Psychol, WHO-Quality of Life Bref-Psychological health; WHO-Social, WHO-Quality
of Life Bref-Social relationships; WHO-Env, WHO-Quality of Life Bref-Environment; GAF, Global Assessment of Functioning scale. ∗Significant time effect, independent of
the type of treatment (EMDR or CBT).
work on trauma reprocessing started (around Assessment-3),
EMDR showed an increase in effectiveness while CBT effects
remained virtually unchanged.
The upturn in depression levels recorded at follow-up in the
EMDR group may have been due to the low volume of EMDR
provided. It might be hypothesized that a greater number of
EMDR sessions would have facilitated more reprocessing of the
pathogenic memories underlying depressive symptoms and thus
the upturn could have been prevented.
As regards the secondary outcome of the study, both
treatments were effective in reducing anxiety and post-traumatic
symptoms even after just a limited number of sessions, with the
benefits still apparent 6 months after the end of the psychological
treatment. EMDR and CBT have both been proven to be
efficacious in treating anxiety and post-traumatic symptoms, and
therefore these results are in agreement with previous literature
(Kar, 2011; Hofmann et al., 2012; Chen Y.-R. et al., 2014).
Furthermore, both treatments were able to significantly
improve Quality of Life (QoL) and global functioning, the
benefits here too persisting beyond the end of the intervention.
The benefits associated with social and environmental QoL
appeared to became apparent faster for the EMDR group, which
also showed considerable improvement in these variables at
the end of therapy, while the CBT group appeared to gain
these benefits at a later stage. This difference could be due to
the different focus of the two psychotherapeutic interventions;
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while CBT focuses mainly on maladaptive beliefs underlying
depression, in EMDR therapy the reprocessing of dysfunctionally
stored memories can lead to changes in different symptoms or
in the impairment of functioning connected to the reprocessed
memory, as proposed in the AIP-Model of EMDR therapy.
Moreover, the majority of patients in our study reported
previous adverse childhood experiences and stressful life
events (e.g., sexual and physical abuse, traumatic mourning,
abandonment, and serious neglect). This finding is in line with
the hypothesis that stressful life events play a significant role in
both the onset and the risk of recurrence of depressive episodes
(Chapman et al., 2004; Nanni et al., 2012; Pietrek et al., 2013;
Nemeroff, 2016).
This study has a number of strengths. It is the first study to
compare the efficacy of EMDR with that of CBT for patients
with depressive disorder treated with ADMs using a randomized
controlled design and evaluating the effects on associated
symptoms and QoL.
Limitations
The number of patients treated with EMDR and CBT included
in the study is not large. As this is the first study attempting to
investigate the non-inferiority of EMDR compared with CBT, it
is possible that actual differences between the two groups were
not revealed due to the design and sample size of the study; future
superiority clinical trials are needed to broaden this investigation.
Moreover, in this study a self-report measure (BDI-II) was used as
the primary outcome measure. Future studies should also include
a clinician report measure administered by an independent rater
in order to overcome this limitation.
Another limitation is that the 6-month follow-up evaluation
was not long enough to examine the recurrence rate of
subsequent depressive episodes. Therefore, longer follow-ups
(e.g., at 1 year or longer) are needed in order to identify possible
differences between the two interventions in reducing the risk
of recurrence of depressive episodes. Lastly, another limitation
of this study was the inclusion of ITT analysis for the primary
outcome only.
Although our results can only be considered preliminary,
this study suggests that EMDR could be as effective as CBT
in reducing depressive symptoms in patients suffering from
recurrent depressive disorder and treated with ADMs. Both
EMDR and CBT as adjunctive interventions to ADMs are
effective in reducing anxiety and post-traumatic symptoms and
increasing QoL, even over a limited number of treatment
sessions.
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